AEterna Zentaris Email Formats
Pharmaceutical Manufacturing • 
Summerville, South Carolina, United States • 21-50 Employees
AEterna Zentaris Email Formats
AEterna Zentaris uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@aezsinc.com), used 80% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@aezsinc.com | 80% |
{first initial}{second initial}{last name} | jodoe@aezsinc.com | 13.3% |
{first name}{last name} | johndoe@aezsinc.com | 6.7% |
Key Contacts at AEterna Zentaris
Matthias Gerlach
Managing Director
Patricia Z.
Director, Administrative Services & Hr Us
Paul Burroughs
Director Of Communications
Anett Wiesemann-Fuhr
Associate Director Pharmacovigilance - Qppv, Stufenplanbeauftragte
Tilmann Schuster
Head Of Production Acc. Amwhv
Beate Aue
Associate Director Clinical Development
Matthias Gerlach
Head Of Production According To Amwhv
Matthias Rischer
Managing Director
Chantal Gravel
Director, Business Operations
Shaniqua Brown
Managing Director
Company overview
| Headquarters | 315 Sigma Drive, Charleston, South Carolina 29486, US |
| Phone number | +18439003201 |
| Website | |
| NAICS | 3254 |
| SIC | 873 |
| Keywords | Endocrinology And Orphan Products |
| Founded | 1990 |
| Employees | 21-50 |
| Socials |
About AEterna Zentaris
Aeterna Zentaris Inc. is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Company’s lead product, Macrilen™ (macimorelin), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). Macrilen™ is currently marketed in the United States through a license agreement with Novo Nordisk and Aeterna Zentaris receives double-digit royalties on sales. Aeterna Zentaris owns all rights to macimorelin outside of the U.S. and Canada. Aeterna Zentaris is also leveraging the clinical success and compelling safety profile of macimorelin to develop it for the diagnosis of child-onset growth hormone deficiency (CGHD), an area of significant unmet need. The Company is actively pursuing business development opportunities for the commercialization of macimorelin in Europe and the rest of the world, in addition to other non-strategic assets to monetize their value.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
AEterna Zentaris has 23 employees across 10 departments.
Departments
Number of employees
AEterna Zentaris Tech Stack
Discover the technologies and tools that power AEterna Zentaris's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Hosting
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Denmark
Poland
Frequently asked questions
4.8
40,000 users
